Signaturefd, LLC Macrogenics Inc Transaction History

Signaturefd, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$4.48 - $10.11 $4,385 - $9,897	979 Added 195.8%	1,479 $14,000
Q3 2023 Nov 03, 2023	SELL	$4.48 - $6.19 $237 - $328	-53 Reduced 9.58%	500 $2,000
Q2 2023 Aug 01, 2023	SELL	$4.62 - $7.54 $4,481 - $7,313	-970 Reduced 63.69%	553 $2,000
Q1 2023 Apr 28, 2023	BUY	$4.82 - $7.24 $4,930 - $7,406	1,023 Added 204.6%	1,523 $10,000
Q3 2022 Nov 08, 2022	BUY	$3.01 - $5.22 $1,505 - $2,610	500 New	500 $2,000
Q2 2022 Aug 10, 2022	SELL	$2.25 - $9.99 $141 - $629	-63 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$8.12 - $16.9 $511 - $1,064	63 New	63 $1,000
Q2 2020 Jul 30, 2020	SELL	$5.2 - $29.12 $2,236 - $12,521	-430 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$4.28 - $12.11 $1,840 - $5,207	430 New	430 $3,000
Q3 2019 Oct 16, 2019	SELL	$12.44 - $17.48 $559 - $786	-45 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$14.51 - $19.71 $652 - $886	45 New	45 $1,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.